Has FDG PET/CT an impact on the management of patients with anal carcinoma?

被引：1
|
作者：
Vercellino, L. [1 ]
de Parades, V. [2 ]
Nataf, V. [1 ]
Kerrou, K. [1 ]
Huchet, V. [1 ]
Bauer, P. [2 ]
Pascal, O. [1 ]
Touboul, E. [3 ]
Montravers, F. [1 ]
Talbot, J. -N. [1 ]
机构：
[1] Univ Paris 06, Hop Tenon, Nucl Med Serv, F-75020 Paris 20, France
[2] Grp Hosp Diaconesses Croix St Simon, Serv Proctol Med Interventionnelle, F-75012 Paris, France
[3] Univ Paris 06, Hop Tenon, Serv Oncol Radiotherapie, F-75020 Paris 20, France
来源：
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2010年 / 34卷 / 02期
关键词：
Anal carcinoma; FDG; PET/CT; Impact on management; POSITRON-EMISSION-TOMOGRAPHY; EPIDERMOID CARCINOMA; CANCER; CT; F-18-FDG; SURVIVAL; TUMORS; HIV-1;
D O I：
10.1016/j.mednuc.2009.12.005
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Purpose. To evaluate the impact of FDG PET/CT on the management of patients referred for the staging and/or the follow-up of anal carcinoma, and PET/CT on patient management. Patients and methods. We included patients referred to our department for anal carcinoma whose therapeutic management was evaluable thanks to follow-up data during at least 6 months. Results. Data of 44 patients were analysed: 22 had PET/CT for initial staging and 36 during follow-up. PET/CT had impact in nine patients out of 44 (20%) and it was relevant in eight of them. Conclusion. FDG PET/CT is an accurate imaging modality in anal cancer, its impact on patient management is more obvious when persistence or recurrence of disease is suspected. (C) 2009 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码：96 / 102
页数：7
相关论文
共 50 条
  • [31] Clinical impact of FDG PET-CT on management decisions in patients with cervical cancer
    Patel, Chirag
    Fleming, Sarah
    Mehta, Kamna
    Cooper, Rachel
    John, Spencer
    Chowdhury, Fahmid
    Scarsbrook, Andrew
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [32] Impact of FDG-PET/CT in the recurrence workup of anal canal cancer.
    Gauthe, M.
    Lievre, A.
    Richard-Molard, M.
    Nascimento, C.
    Edeline, V.
    Champion, L.
    Wartsky, M.
    Jehanno, N.
    Petras, S.
    Mitry, E.
    Alberini, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S234 - S234
  • [33] Impact of FDG-PET/CT in patients with radioiodine-negative differentiated thyroid carcinoma
    Mustafa, Mona
    Ilhan, Harun
    Haug, Alexander
    Bartenstein, Peter
    Rominger, Axel
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [34] Impact of F-18 FDG PET/CT in pretreatment evaluation of patients with cervical carcinoma
    Akkas, B. E.
    Demirel, B. B.
    Vural, G. U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S366 - S367
  • [35] Importance of screening for synchronous malignant neoplasms in patients with hepatocellular carcinoma: impact of FDG PET/CT
    Hiraoka, Atsushi
    Hirooka, Masashi
    Ochi, Hironori
    Koizumi, Yohei
    Shimizu, Yuko
    Shiraishi, Akiko
    Yamago, Hiroka
    Tanihira, Tetsuya
    Miyata, Hideki
    Ninomiya, Tomoyuki
    Kawasaki, Hideki
    Ishimaru, Yoshihiro
    Sogabe, Ichiro
    Inoue, Takeshi
    Abe, Masanori
    Hiasa, Yoichi
    Matsuura, Bunzo
    Onji, Morikazu
    Michitaka, Kojiro
    LIVER INTERNATIONAL, 2013, 33 (07) : 1085 - 1091
  • [36] Importance of Screening for Synchronous Malignant Neoplasms in Patients With Hepatocellular Carcinoma: Impact of FDG PET/CT
    Hiraoka, Atsushi
    Shiraishi, Akiko
    Sogabe, Ichiro
    Imai, Yusuke
    Tatsukawa, Haruka
    Yamago, Hiroka
    Shimizu, Yuko
    Tanihira, Tetsuya
    Miyata, Hideki
    Ninomiya, Tomoyuki
    Murakami, Tadashi
    Ishimaru, Yoshihiro
    Inoue, Takeshi
    Kawasaki, Hideki
    Hirooka, Masashi
    Matsuura, Bunzo
    Hiasa, Yoichi
    Onji, Morikazu
    Michitaka, Kojiro
    GASTROENTEROLOGY, 2013, 144 (05) : S720 - S720
  • [37] Clinical impact of FDG PET/CT in the pretreatment evaluation of patients with locally advanced cervical carcinoma
    Akkas, Burcu
    Demirel, Busra
    Vural, Gulin
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [38] The Role of 18F-FDG PET/CT in Restaging and Management of Patients with Colorectal Carcinoma
    Mateva, G.
    Kostadinova, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S699 - S699
  • [39] Clinical impact of (18)F-FDG PET-CT in the management of patients with carcinoma of unknown primary: our experience
    Paone, G.
    Treglia, G.
    Ruberto, T.
    Ceriani, L.
    Giovanella, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S482 - S482
  • [40] Clinical impact of FDG PET on the management of patients with pancreatic carcinoma: Comparison with CT and CA19-9 serology.
    Jadvar, H
    Fischman, AJ
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 104P - 104P
12345